{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.1444.3.157","meta":{"versionId":"6","lastUpdated":"2021-05-21T01:00:57.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"American Society of Clinical Oncology Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2023-04-24"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2021-05-21"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.157","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.1444.3.157"}],"version":"20210521","name":"BelinostatInjectable","title":"Belinostat Injectable","status":"active","experimental":false,"date":"2021-05-21T01:00:57-04:00","publisher":"American Society of Clinical Oncology Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: The purpose of this value set is to represent concepts of medication Belinostat.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication Belinostat; generic; prescribable; injectable.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.)","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","concept":[{"code":"1543547","display":"belinostat 500 MG Injection"}]}]},"expansion":{"identifier":"urn:uuid:53bdfd73-09e4-4b85-9d0b-d6a98ee49a3e","timestamp":"2023-12-11T01:18:40-05:00","total":1,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1543547","display":"belinostat 500 MG Injection"}]}}